414 related articles for article (PubMed ID: 17184870)
1. N-sulfonato-N,O-carboxymethylchitosan: a novel polymeric absorption enhancer for the oral delivery of macromolecules.
Thanou M; Henderson S; Kydonieus A; Elson C
J Control Release; 2007 Feb; 117(2):171-8. PubMed ID: 17184870
[TBL] [Abstract][Full Text] [Related]
2. Mono-N-carboxymethyl chitosan (MCC), a polyampholytic chitosan derivative, enhances the intestinal absorption of low molecular weight heparin across intestinal epithelia in vitro and in vivo.
Thanou M; Nihot MT; Jansen M; Verhoef JC; Junginger HE
J Pharm Sci; 2001 Jan; 90(1):38-46. PubMed ID: 11064377
[TBL] [Abstract][Full Text] [Related]
3. A mucoadhesive nanoparticulate system for the simultaneous delivery of macromolecules and permeation enhancers to the intestinal mucosa.
Makhlof A; Werle M; Tozuka Y; Takeuchi H
J Control Release; 2011 Jan; 149(1):81-8. PubMed ID: 20138935
[TBL] [Abstract][Full Text] [Related]
4. Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs.
van der Merwe SM; Verhoef JC; Verheijden JH; Kotzé AF; Junginger HE
Eur J Pharm Biopharm; 2004 Sep; 58(2):225-35. PubMed ID: 15296951
[TBL] [Abstract][Full Text] [Related]
5. Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells.
Sadeghi AM; Dorkoosh FA; Avadi MR; Weinhold M; Bayat A; Delie F; Gurny R; Larijani B; Rafiee-Tehrani M; Junginger HE
Eur J Pharm Biopharm; 2008 Sep; 70(1):270-8. PubMed ID: 18492606
[TBL] [Abstract][Full Text] [Related]
6. Bioactive self-assembling lipid-like peptides as permeation enhancers for oral drug delivery.
Karavasili C; Spanakis M; Papagiannopoulou D; Vizirianakis IS; Fatouros DG; Koutsopoulos S
J Pharm Sci; 2015 Jul; 104(7):2304-11. PubMed ID: 25994901
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of paracellular drug transport with highly quaternized N-trimethyl chitosan chloride in neutral environments: in vitro evaluation in intestinal epithelial cells (Caco-2).
Kotzé AF; Thanou MM; Luebetaen HL; de Boer AG; Verhoef JC; Junginger HE
J Pharm Sci; 1999 Feb; 88(2):253-7. PubMed ID: 9950647
[TBL] [Abstract][Full Text] [Related]
8. Effect of salt forms and molecular weight of chitosans on in vitro permeability enhancement in intestinal epithelial cells (Caco-2).
Opanasopit P; Aumklad P; Kowapradit J; Ngawhiranpat T; Apirakaramwong A; Rojanarata T; Puttipipatkhachorn S
Pharm Dev Technol; 2007; 12(5):447-55. PubMed ID: 17963144
[TBL] [Abstract][Full Text] [Related]
9. Chitosan ascorbate: a chitosan salt with improved penetration enhancement properties.
Rossi S; Marciello M; Sandri G; Bonferoni MC; Ferrari F; Caramella C
Pharm Dev Technol; 2008; 13(6):513-21. PubMed ID: 18720244
[TBL] [Abstract][Full Text] [Related]
10. N-trimethyl chitosan chloride as a potential absorption enhancer across mucosal surfaces: in vitro evaluation in intestinal epithelial cells (Caco-2).
Kotzé AF; Luessen HL; de Leeuw BJ; de Boer BG; Verhoef JC; Junginger HE
Pharm Res; 1997 Sep; 14(9):1197-202. PubMed ID: 9327448
[TBL] [Abstract][Full Text] [Related]
11. Modulation of ganciclovir intestinal absorption in presence of absorption enhancers.
Shah P; Jogani V; Mishra P; Mishra AK; Bagchi T; Misra A
J Pharm Sci; 2007 Oct; 96(10):2710-22. PubMed ID: 17680662
[TBL] [Abstract][Full Text] [Related]
12. Chitosan citrate as multifunctional polymer for vaginal delivery. Evaluation of penetration enhancement and peptidase inhibition properties.
Bonferoni MC; Sandri G; Rossi S; Ferrari F; Gibin S; Caramella C
Eur J Pharm Sci; 2008 Feb; 33(2):166-76. PubMed ID: 18248966
[TBL] [Abstract][Full Text] [Related]
13. Intestinal permeation enhancers enable oral delivery of macromolecules up to 70 kDa in size.
Fein KC; Gleeson JP; Newby AN; Whitehead KA
Eur J Pharm Biopharm; 2022 Jan; 170():70-76. PubMed ID: 34879228
[TBL] [Abstract][Full Text] [Related]
14. Development of a Non-Aqueous Dispersion to Improve Intestinal Epithelial Flux of Poorly Permeable Macromolecules.
Maher S; Medani M; Carballeira NN; Winter DC; Baird AW; Brayden DJ
AAPS J; 2017 Jan; 19(1):244-253. PubMed ID: 27739012
[TBL] [Abstract][Full Text] [Related]
15. N-trimethyl chitosan chloride: optimum degree of quaternization for drug absorption enhancement across epithelial cells.
Hamman JH; Schultz CM; Kotzé AF
Drug Dev Ind Pharm; 2003 Feb; 29(2):161-72. PubMed ID: 12648013
[TBL] [Abstract][Full Text] [Related]
16. Improvement of intestinal absorption of insulin and water-soluble macromolecular compounds by chitosan oligomers in rats.
Gao Y; He L; Katsumi H; Sakane T; Fujita T; Yamamoto A
Int J Pharm; 2008 Jul; 359(1-2):70-8. PubMed ID: 18450395
[TBL] [Abstract][Full Text] [Related]
17. Discovery of synergistic permeation enhancers for oral drug delivery.
Whitehead K; Karr N; Mitragotri S
J Control Release; 2008 Jun; 128(2):128-33. PubMed ID: 18433909
[TBL] [Abstract][Full Text] [Related]
18. Nanoparticles based on N-trimethylchitosan: evaluation of absorption properties using in vitro (Caco-2 cells) and ex vivo (excised rat jejunum) models.
Sandri G; Bonferoni MC; Rossi S; Ferrari F; Gibin S; Zambito Y; Di Colo G; Caramella C
Eur J Pharm Biopharm; 2007 Jan; 65(1):68-77. PubMed ID: 16962751
[TBL] [Abstract][Full Text] [Related]
19. Sodium caprate-induced increases in intestinal permeability and epithelial damage are prevented by misoprostol.
Brayden DJ; Maher S; Bahar B; Walsh E
Eur J Pharm Biopharm; 2015 Aug; 94():194-206. PubMed ID: 26026287
[TBL] [Abstract][Full Text] [Related]
20. Studies on the intestinal absorption of low molecular weight heparin using saturated fatty acids and their derivatives as an absorption enhancer in rats.
Mori S; Matsuura A; Rama Prasad YV; Takada K
Biol Pharm Bull; 2004 Mar; 27(3):418-21. PubMed ID: 14993814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
